Maxima Health Research has been providing regulatory assistance to multinational pharmaceutical companies since 2002, building a track record of success in navigating the complex and ever-evolving regulatory landscape of Russia, Ukraine, Eurasia, and other CIS countries. Over its history, Maxima has accomplished hundreds of product registrations and has arranged over 1,000 different approvals for a wide range of pharmaceutical products, health supplements, medical devices, cosmetics, and clinical nutrition products. The company has also overseen Post Phase III Studies and arranged regulatory and pharmacovigilance trainings for companies. With its deep expertise and comprehensive approach to regulatory support, Maxima has successfully registered all different types of pharma products, including biosimilars, generics, and innovative products. The company has also been audited by local MOHs as well as world-renowned companies, attesting to its high standards of quality and regulatory compliance. In addition to these core services, Maxima provides a range of complementary services to support its clients' regulatory needs, such as medical translations, labeling and packaging adaptation, and other regulatory support functions. With its long history of success, deep expertise, and commitment to quality and regulatory compliance, Maxima Health Research is a trusted partner for over 100 international companies, ranging from biotech to probiotic, who require fast approvals, launch, post-launch maintenance of their products, and end-to-end regulatory support in Russia, Ukraine, Eurasia, and other CIS countries.
